BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 7817735)

  • 21. Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study.
    Jensen JT; Astley SJ; Morgan E; Nichols MD
    Contraception; 1999 Mar; 59(3):153-9. PubMed ID: 10382077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood loss in termination of early pregnancy with mifepristone and gemeprost.
    Prasad RN; Choolani M; Roy A; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1995 Aug; 35(3):329-31. PubMed ID: 8546658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further acceptability evaluation of RU486 and ONO 802 as abortifacient agents in a Chinese population.
    Tang GW; Lau OW; Yip P
    Contraception; 1993 Sep; 48(3):267-76. PubMed ID: 8222656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care.
    Slade P; Heke S; Fletcher J; Stewart P
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1288-95. PubMed ID: 9883920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical abortion in Britain.
    Baird DT
    Br J Obstet Gynaecol; 1994 May; 101(5):367-8. PubMed ID: 8018604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is misoprostol the drug of choice for induced cervical ripening in early pregnancy termination?
    Platz-Christensen JJ; Nielsen S; Hamberger L
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):809-12. PubMed ID: 8533565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
    Rodger MW; Baird DT
    Contraception; 1989 Oct; 40(4):439-47. PubMed ID: 2582769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
    Thong KJ; Baird DT
    Contraception; 1992 Jul; 46(1):11-7. PubMed ID: 1424619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
    Bartley J; Tong S; Everington D; Baird DT
    Contraception; 2000 Dec; 62(6):297-303. PubMed ID: 11239616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of vaginal misoprostol and gemeprost as pre-treatment in first trimester pregnancy interruption.
    Henry AM; Haukkamaa M
    Br J Obstet Gynaecol; 1999 Jun; 106(6):540-3. PubMed ID: 10426610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost).
    Rodger MW; Logan AF; Baird DT
    Contraception; 1989 May; 39(5):497-502. PubMed ID: 2656087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Martin CW; Brown AH; Baird DT
    Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women's evaluation of three early abortion methods.
    Holmgren K
    Acta Obstet Gynecol Scand; 1992 Dec; 71(8):616-23. PubMed ID: 1336921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation.
    Bartley J; Brown A; Elton R; Baird DT
    Hum Reprod; 2001 Oct; 16(10):2098-102. PubMed ID: 11574498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases.
    Tang OS; Thong KJ; Baird DT
    Contraception; 2001 Jul; 64(1):29-32. PubMed ID: 11535210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical preparation for first trimester surgical abortion.
    Kapp N; Lohr PA; Ngo TD; Hayes JL
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007207. PubMed ID: 20166091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study.
    Rørbye C; Nørgaard M; Nilas L
    Contraception; 2004 Nov; 70(5):393-9. PubMed ID: 15504379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation.
    Ashok PW; Kidd A; Flett GM; Fitzmaurice A; Graham W; Templeton A
    Hum Reprod; 2002 Jan; 17(1):92-8. PubMed ID: 11756368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in circulating alphafetoprotein following administration of mifepristone in first trimester pregnancy.
    Chard T; Olajide F; Kitau M
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1030-2. PubMed ID: 1701323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases.
    Gemzell-Danielsson K; Ostlund E
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):702-6. PubMed ID: 10949238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.